Hepatitis B and C are liver infections caused by the hepatitis B virus (HBV) and hepatitis C virus (HCV) respectively. Both conditions can lead to serious, chronic health issues, including liver cirrhosis and liver cancer. Early detection through testing is crucial for effective management and reducing the risk of transmission. DRMED Diagnostic Clinic & Laboratory offers HBsAG and HCV ELISA tests to aid in the early diagnosis of these conditions.

Understanding Hepatitis B and C

Hepatitis B is often spread through contact with infected bodily fluids, while hepatitis C is primarily spread through blood-to-blood contact. Both diseases may initially present with no symptoms, making them difficult to detect without screening.

The Significance of HBsAG and HCV ELISA Tests

The HBsAG (Hepatitis B surface antigen) test is used to detect the presence of the hepatitis B virus. A positive result indicates that the person is infectious and can spread the virus to others.

The HCV ELISA (Hepatitis C virus enzyme-linked immunosorbent assay) test is used to detect antibodies to the hepatitis C virus, indicating a past or present infection.

Treatment Pathways

While there is no cure for hepatitis B, treatments can reduce the risk of liver disease and prevent transmission. Vaccination is available and recommended for hepatitis B. For hepatitis C, advancements in antiviral medications can cure most cases of the infection.

Understanding your risks and getting screened for hepatitis B and C are critical steps in managing your health. DRMED Diagnostic Clinic & Laboratory provides comprehensive testing and consultation to help you understand your results and your options.